SCHEMBL248738

SCHEMBL248738

Cc1cc(C)c(C(=O)OC(=O)c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.41
ACHE P22303 1/20 0.41
ALDH1A1 P00352 5/20 0.40
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
TAS1R2 Q8TE23 2/20 0.40
HPGD P15428 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
GLO1 Q04760 1/20 0.38
TPMT P51580 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL18982856 0.98 CYP3A4 (0.39) CYP3A4ACHEALDH1A1TAS1R3TAS1R1
SCHEMBL29871279 0.88 CYP3A4 (0.39) CYP3A4ACHEALDH1A1TAS1R3TAS1R1
Phosphine SCHEMBL27837145 0.87 POLB (0.38) CYP3A4ACHEALDH1A1TAS1R3TAS1R1
SCHEMBL27483844 0.87 CYP3A4 (0.36) CYP3A4ACHEALDH1A1TAS1R3TAS1R1
SCHEMBL28046820 0.87 KDM4E (0.38) CYP3A4ACHEALDH1A1TAS1R3TAS1R1
SCHEMBL125935 0.85 CYP3A4 (0.41) CYP3A4ACHEALDH1A1TAS1R3TAS1R1
SCHEMBL27356152 0.85 CYP3A4 (0.35) CYP3A4ACHEALDH1A1TAS1R3TAS1R1
Biphenyl SCHEMBL19066843 0.84 SMN1; SMN2 (0.41) ALDH1A1HPGDSMN1; SMN2KDM4EL3MBTL1
SCHEMBL248739 0.84 TSHR (0.47) ALDH1A1HPGDMEN1LMNAKMT2A
Water SCHEMBL27685547 0.83 CYP3A4 (0.34) CYP3A4ACHEALDH1A1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119752442-A Method for preparing different fluorescence emission carbon points in large scale through solvent engineering 中南大学 2025-04-04 CN claimed
CN-117986435-A Preparation method of medical photo-curing 3D printing resin 深圳光华伟业股份有限公司 2024-05-07 CN claimed
CN-117658816-A Novel ethylenically unsaturated monomer and preparation method thereof 深圳有为技术控股集团有限公司 2024-03-08 CN claimed
EP-4277938-A1 METHOD FOR PRODUCING MATERIALLY STRUCTURED AND/OR FUNCTIONALLY STRUCTURED COMPONENTS Leibniz-Institut für Polymerforschung Dresden e.V. (DE) 2023-11-22 EP claimed
CN-114989217-A Synthetic method of 2,4,6-trimethylbenzoyl-diphenyl phosphine oxide 厦门大学 2022-09-02 CN claimed
WO-2022152654-A1 METHOD FOR PRODUCING MATERIALLY STRUCTURED AND/OR FUNCTIONALLY STRUCTURED COMPONENTS LEIBNIZ-INSTITUT FÜR POLYMERFORSCHUNG DRESDEN E.V. (DE) 2022-07-21 WO claimed
CN-110358493-A A kind of ultraviolet light solidification reworkable waterproof gasket cement of in-situ polymerization 上海汉司实业有限公司 2019-10-22 CN claimed
CN-109941026-A A kind of floor surface digital printing archaizing processing technology 谭宏伟 2019-06-28 CN claimed
CN-109897528-A A kind of modified coating and the preparation method and application thereof 安庆北化大科技园有限公司 2019-06-18 CN claimed
CN-109593397-A It is a kind of suitable for intaglio printing and with special artistic effect aqueous UV ink 汕头东风印刷股份有限公司 2019-04-09 CN claimed
CN-105525385-B A kind of multi-layer core-shell nano fiber scaffold and its method with melanocyte building tissue engineering material 杭州市第三人民医院 2018-12-25 CN claimed
CN-108676201-A Biology base environment-friendlydegradable degradable material, by the preparation method of its film and its film obtained 苏州汉丰新材料股份有限公司 2018-10-19 CN claimed
EP-1543074-B1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO LTD (KR) 2008-02-27 EP claimed
US-7046904-B2 UV-curable resin composition for cladding optical fiber SSCP CO., LTD. (KR) 2006-05-16 US claimed
US-20060067638-A1 Uv-curable resin composition for cladding optical fiber LUVANTIX CO., LTD. (KR) 2006-03-30 US claimed
EP-1543074-A4 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO LTD (KR) 2006-01-04 EP claimed
EP-1543074-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP Co., Ltd. (KR) 2005-06-22 EP claimed
WO-2004024814-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO., LTD. (KR) 2004-03-25 WO claimed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
US-3978032-A ALKALINE BUFFER, ANHYDRIDE, PERACID, ALKYL HALOFORMATE PPG INDUSTRIES, INC. (US) 1976-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same ASH2L, OLA1, ODC1 CYP3A4 2447/4885ACHE 612/4885ALDH1A1 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.